AstraZeneca
This role supports cell therapy process characterization and commercialization by advancing late-stage process development, PPQ readiness, and technology transfer. The position focuses on cell therapy unit operations, including T-cell enrichment, activation, transduction, and harvest, utilizing both semi-automated and automated equipment. The ideal candidate will leverage technical expertise and hands-on experience to ensure clinical and commercial readiness for cell therapy manufacturing.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
3% below the average for this role
US: Program Lead, Cell and Gene Therapy
Legend Biotech
Principal Scientist/Director, Biologics Drug Substance Commercialization
MSD
Senior Director, Late Stage Cell Therapy Process Development
Sana Biotechnology
Associate Principal Scientist/Associate Director, Engineering- Biologics Drug Substance Commercialization
MSD
Principal Scientist, Process Development & Commercialization
Merck & Co., Inc.
Principal Engineer, or Principal Scientist
Bora Pharmaceuticals